Cargando…

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy

BACKGROUND: Malignant Pleural Mesothelioma (MPM) is a dreadful disease escaping the classical genetic model of cancer evolution and characterized by wide heterogeneity and transcriptional plasticity. Clinical evolution of MPM is marked by a progressive transdifferentiation that converts well differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torricelli, F, Donati, B, Reggiani, F, Manicardi, V, Piana, S, Valli, R, Lococo, F, Ciarrocchi, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351128/ https://www.ncbi.nlm.nih.gov/pubmed/37460925 http://dx.doi.org/10.1186/s12943-023-01816-9

Ejemplares similares

Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma
por: Torricelli, Federica, et al.
Publicado: (2020)

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
por: Lorenzini, Eugenia, et al.
Publicado: (2022)

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
por: Lorenzini, Eugenia, et al.
Publicado: (2021)

Malignant Pleural Mesothelioma: Time Is Running Out
por: Lococo, Filippo
Publicado: (2021)

Metastatic biphasic pleural mesothelioma presenting with cauda equina syndrome
por: Pranay, Pritesh, et al.
Publicado: (2018)

A Single Liver Metastasis from Pleural Biphasic Mesothelioma
por: Marzullo, Andrea, et al.
Publicado: (2020)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor
por: Gleason, James Benjamin, et al.
Publicado: (2016)

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype
por: Giusti, Laura, et al.
Publicado: (2016)

Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers
por: Bruno, Rossella, et al.
Publicado: (2022)

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
por: Vita, Emanuele, et al.
Publicado: (2021)

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)

The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1
por: Gallo, Cristina, et al.
Publicado: (2018)

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
por: Borgeaud, Maxime, et al.
Publicado: (2023)

A Biphasic Pleural Tumor with Features of an Epithelioid and Small Cell Mesothelioma: Morphologic and Molecular Findings
por: Hackman, Sarah, et al.
Publicado: (2016)

The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma
por: Lettieri, Sara, et al.
Publicado: (2021)

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
por: Vitale, Emanuele, et al.
Publicado: (2022)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
por: Manente, Arcangela G., et al.
Publicado: (2015)

Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor
por: Salazar, Carlos, et al.
Publicado: (2018)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
por: Torricelli, Federica, et al.
Publicado: (2023)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

An appropriate choice for immunotherapy in malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2020)

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
por: Banerji, Shantanu, et al.
Publicado: (2021)

ADAM10 mediates malignant pleural mesothelioma invasiveness
por: Sépult, Christelle, et al.
Publicado: (2019)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
por: Tsuji, S, et al.
Publicado: (2010)

Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years’ Experience at a High-Volume Referral Center
por: Iaffaldano, Amedeo, et al.
Publicado: (2021)

Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
por: David, Jill, et al.
Publicado: (2022)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
por: Hearon, Bernard F., et al.
Publicado: (2020)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pisup8nkmc2p8p1t7rg50aupte